Health Condition 1: K601- Chronic anal fissure
Conditions
Interventions
Intervention1: GROUP B( 7%sucralfate group)-0.3 % NIFEDIPINE,
1.5% LIGNOCAINE ALONG WITH 7% SUCRALFATE: TREATMENT PLANNED FOR THE PATIENT IS 0.3 % NIFEDIPINE,
1.5% LIGNOCAINE ALONG WITH 7% SUCRALFAT
Sponsors
JIPMER
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria Patients coming to JIPMER general surgery OPD and casualty during the study period fulfilling the following criteria All patients with Chronic fissure in ano (symptoms >6 weeks, fissure with hypertrophied anal papilla and sentinel pile) above 18yrs age
Exclusion criteria
Exclusion criteria: Exclusion criteria: 1.Patients with cardiovascular illness, heart failure, diabetes 2.Patient having secondary causes if fissure such as HIV/AIDS, inflammatory bowel disease, malignancy and dermatological conditions like psoriasis. 3.Patients taking Diltiazem or Nifedipine drug. 4.Patients on chronic use of analgesics such as for head-ache 5.Patient denying consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the effectiveness of Topical sucralfate with standard of care and standard of care alone in relieving pain of patients with Chronic Fissure in Ano at 2 weeks. (Drugs used in standard of care are 0.3% Nifedipine and 1.5 % Lignocaine cream) Timepoint: 2 WEEKS | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the healing in both the groups To compare the anal bleeding in both the groupsTimepoint: 2 weeks | — |
Countries
India
Contacts
Public ContactDR B TEJA KUMAR GOUD
JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH
Outcome results
None listed